Roshanak DERAKHSHANDEH, Yiannis Petros DİMOPOULOS, Todd Alan GOODGLİCK, Joeffrey CHANİNE, Sina SABET, Metin ÖZDEMİRLİ

Single Institutional Experience on Orbital Inflammatory Pseudotumor: Diagnostic and Management Challenge

Aims: Orbital inflammatory pseudotumor is considered a non-neoplastic inflammatory process. The finding of clonality of B or T-cell receptors in cases pathologically diagnosed as orbital inflammatory pseudotumor has unknown clinicopathologic significance. We sought to investigate potential B and T-cell clonality and concomitant diseases in cases pathologically diagnosed as orbital inflammatory pseudotumor. Methods: Cases diagnosed as orbital inflammatory pseudotumor at our institution were retrospectively analyzed. Hematoxylin and eosinstained slides, immunohistochemically stained slides and polymerase chain reactions on cell block material for the investigation of clonality of B and T-cell receptors were evaluated, to confirm the diagnosis and investigate the prevalence of concomitant diseases. Results: A total of 13 cases showing characteristic histopathologic features of orbital inflammatory pseudotumor were identified. CD138, IgG, and IgG4 showed varying numbers of plasma cells in each case, with 5 cases (5/13, 38%) exhibiting relative increase in the presence of IgG4 plasma cells. However, no cases showed diagnostic findings of IgG4-related disease (IgG4-RD). polymerase chain reactions analysis showed clonal B-cell populations in 2 cases (2/13, 15%). No cases showed anaplastic lymphoma kinase expression by immunohistochemistry. There were no clinical reports of progression to lymphoma or development of systemic IgG4-RD in any of the patients (average follow-up of 300 days), with 38% of patients showing systemic autoimmune conditions. Conclusion: A small but significant percentage of typical orbital inflammatory pseudotumor on histology showed B-cell clonality on polymerase chain reactions analysis of B-cell receptors, or features suggestive, but not diagnostic of IgG4-RD. Close follow-up of these patients to identify development of lymphoma, systemic IgG4-RD, or other rheumatologic conditions may be clinically warranted.

PDF

___

1. Surabhi VR, Chua S, Patel RP, et al. Inflammatory myofibroblastic tumors: current update. Radiol Clin North Am. 2016;54:553-563. [CrossRef]
2. Umiker WO, Iverson L. Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J Thorac Surg. 1954;28:55-63. [CrossRef]30758-3)
3. Kamili MA, G A, Dar IH, et al. Orbital pseudotumor. Oman J Ophthalmol. 2009;2:96- 99. [CrossRef]
4. Mahr MA, Salomao DR, Garrity JA. Inflammatory orbital pseudotumor with extension beyond the orbit. Am J Ophthalmol. 2004;138:396-400. [CrossRef]
5. Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol. 2008;15:17-27. [CrossRef]
6. Das D, Deka P, Bhattacharjee K, et al. Idiopathic inflammatory diseases of orbit and ocular adnexa: histopathological and immunochemical analysis. Indian J Ophthalmol. 2019;67:1993-1995. [CrossRef]
7. Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond). 2006;20:1196-1206. [CrossRef]
8. Yan J, Wu Z, Li Y. The differentiation of idiopathic inflammatory pseudotumor from lymphoid tumors of orbit: analysis of 319 cases. Orbit. 2004;23:245-254. [CrossRef]
9. Yeşiltaş YS, Gündüz AK. Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol. 2018;25:71-80. [CrossRef]
10. Spindle J, Tang SX, Davies B, et al. Pediatric idiopathic orbital inflammation: clinical features of 30 cases. Ophthal Plast Reconstr Surg. 2016;32:270-274. [CrossRef]
11. Ren J, Yuan Y, Wu Y, Tao X. Differentiation of orbital lymphoma and idiopathic orbital inflammatory pseudotumor: combined diagnostic value of conventional MRI and histogram analysis of ADC maps. BMC Med Imaging. 2018;18:6. [CrossRef]
12. Chougule A, Bal A. IgG4-related inflammatory pseudotumor: A systematic review of histopathological features of reported cases. Mod Rheumatol. 2017;27:320-325. [CrossRef]
13. Lee CS, Harocopos GJ, Kraus CL, et al. IgG4-associated orbital and ocular inflammation. J Ophthal Inflamm Infect. 2015;5:15. [CrossRef]
14. Obiorah IE, Henao Velasquez A, Özdemirli M. The clinicopathologic spectrum of IgG4-related disease. Balk Med J. 2018;35:292-300. [CrossRef]
15. Kaitoukov Y, Rakovich G, Trahan S, Grégoire J. Inflammatory pseudotumour of the lung. Can Respir J. 2011;18:315-317. [CrossRef]
16. Tao J, Zhou ML, Zhou SH. Inflammatory myofibroblastic tumors of the head and nec. Int J Clin Exp Med. 2015;8:1604-1610.
17. Kahana A. Orbital inflammatory disorders: new knowledge, future challenges. Curr Opin Ophthalmol. 2021;32:255-261. [CrossRef]
18. Rico M, Díaz-López JB, Peña J, Oliva-Nacarino P. Latent orbital pseudotumor secondary to systemic lupus erythematosus. Clin Case Rep. 2016;4:1065-1067. [CrossRef]
19. Tsukikawa M, Lally SE, Shields CL, et al. Idiopathic orbital pseudotumor preceding systemic inflammatory disease in children. J Pediatr Ophthalmol Strabismus. 2019;56:373-377. [CrossRef]
20. Zhang BX, Chen ZH, Liu Y, Zeng YJ, Li YC. Inflammatory pseudotumor-like follicular dendritic cell sarcoma: A brief report of two cases. World J Gastrointest Oncol. 2019;11:1231-1239. [CrossRef]
21. Mejico LJ. IgG4-related ophthalmic disease. Saudi J Ophthalmol. 2015;29:53-56. [CrossRef]
22. Ryu G, Cho HJ, Lee KE, et al. Clinical significance of IgG4 in sinonasal and skull base inflammatory pseudotumor. Eur Arch Otorhinolaryngol. 2019;276:2465-2473. [CrossRef]
23. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509- 520. [CrossRef]
24. Yamamoto H, Oda Y, Saito T, et al. p53 mutation and MDM2 amplification in inflammatory myofibroblastic tumours. Histopathology. 2003;42:431-439. [CrossRef]
25. Matsuo T, Sato Y, Kuroda R, Matsuo N, Yoshino T. Systemic malignant lymphoma 17 years after bilateral orbital pseudotumor. Jpn J Ophthalmol. 2004;48:503-506. [CrossRef]